{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:06:59Z","timestamp":1792807619551,"version":"4.5.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T00:00:00Z","timestamp":1442966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0134971","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T18:11:29Z","timestamp":1443031889000},"page":"e0134971","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Diabetes Mellitus and Prediabetes on Kidney Transplant Waiting List- Prevalence, Metabolic Phenotyping and Risk Stratification Approach"],"prefix":"10.1371","volume":"10","author":[{"given":"Martina","family":"Guthoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Vosseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Langanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Nadalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"K\u00f6nigsrainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"H\u00e4ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Heyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,23]]},"reference":[{"key":"ref1","unstructured":"United States Renal Data System, Annual Report 2013"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"E307","DOI":"10.1111\/j.1399-0012.2012.01661.x","article-title":"Access to renal transplantation in the diabetic population-effect of comorbidities and body mass index","volume":"26","author":"BK Patibandla","year":"2012","journal-title":"Clin Transplant"},{"key":"ref3","first-page":"248","article-title":"Outcome of kidney transplantation in type 1 and type 2 diabetic patients and recipients with posttransplant diabetes mellitus","volume":"5","author":"B Einollahi","year":"2008","journal-title":"Urol J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00400421","article-title":"Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study","volume":"39","author":"G Nijpels","year":"1996","journal-title":"Diabetologia"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diabres.2007.05.004","article-title":"Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies","volume":"78","author":"HC Gerstein","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1399-0012.2006.00580.x","article-title":"Predictors of new onset diabetes after renal transplantation","volume":"21","author":"N Joss","year":"2007","journal-title":"Clin Transplant"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2337\/dc11-0752","article-title":"Pretransplant risk score for new-onset diabetes after kidney transplantation","volume":"34","author":"HA Chakkera","year":"2011","journal-title":"Diabetes Care"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2002.kid582.x","article-title":"Patient survival after renal transplantation: IV. Impact of post-transplant diabetes","volume":"62","author":"FG Cosio","year":"2002","journal-title":"Kidney Int"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"BL Kasiske","year":"2003","journal-title":"Am J Transplant"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1034\/j.1600-6143.2003.00082.x","article-title":"Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients","volume":"3","author":"RS Woodward","year":"2003","journal-title":"Am J Transplant"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2215\/CJN.04681107","article-title":"Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival","volume":"3","author":"EH Cole","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/ndt\/gfg338","article-title":"A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients","volume":"18","author":"M Hagen","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/00007890-200105270-00011","article-title":"beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus","volume":"71","author":"JH Nam","year":"2001","journal-title":"Transplantation"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/oxfordjournals.ndt.a027841","article-title":"Insulin resistance is a common denominator of post-transplant diabetes mellitus and impaired glucose tolerance in renal transplant recipients","volume":"13","author":"K Midtvedt","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2337\/dc12-1894","article-title":"Pancreatic \u03b2-cell dysfunction and risk of new-onset diabetes after kidney transplantation","volume":"36","author":"DM Zelle","year":"2013","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2337\/dc12-2441","article-title":"Glucose metabolism after renal transplantation","volume":"36","author":"M Hecking","year":"2013","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1681\/ASN.2013040383","article-title":"Genetics of New-Onset Diabetes after Transplantation","volume":"25","author":"JA McCaughan","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00228-012-1292-8","article-title":"Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus","volume":"68","author":"M Kurzawski","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"ref19","first-page":"838A","article-title":"Undiagnosed glucose metabolism disorders in dialysis patients: An analysis using oral glucose tolerance tests in German dialysis centers [abstract]","volume":"22","author":"B Kr\u00e4mer","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 1","key":"ref20","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus","volume":"3","year":"2010","journal-title":"Diabetes Care"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"DR Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing","volume":"22","author":"M Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4239\/wjd.v1.i2.36","article-title":"Surrogate markers of insulin resistance: A review","volume":"1","author":"B Singh","year":"2010","journal-title":"World J Diabetes"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/TP.0b013e31820f0877","article-title":"Incidence and risk factors of glucose metabolism disorders in kidney transplant recipients: role of systematic screening by oral glucose tolerance test","volume":"91","author":"S Caillard","year":"2011","journal-title":"Transplantation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.2010010031","article-title":"Diagnostic application of the A(1c) assay in renal disease","volume":"21","author":"A Sharif","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1440-1797.2011.01517.x","article-title":"Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring","volume":"17","author":"FE Vos","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2337\/db06-1776","article-title":"Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis","volume":"56","author":"G Bock","year":"2007","journal-title":"Diabetes"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2215\/CJN.05360709","article-title":"New-onset diabetes mellitus after kidney transplantation in Denmark","volume":"5","author":"M Hornum","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref29","unstructured":"Organ Procurement and Transplantation Network (OPTN), data reports. Available at <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/optn.transplant.hrsa.gov\/converge\/latestData\/rptData.asp\" xlink:type=\"simple\">http:\/\/optn.transplant.hrsa.gov\/converge\/latestData\/rptData.asp<\/ext-link>. Accessed 5 December 2014."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.metabol.2004.06.014","article-title":"Analysis of the relationship between body mass index, insulin resistance, and beta-cell function: a cross-sectional study using the minimal model","volume":"53","author":"DA Garca-Est\u00e9vez","year":"2004","journal-title":"Metabolism"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1681\/ASN.2011080835","article-title":"Early basal insulin therapy decreases new-onset diabetes after renal transplantation","volume":"23","author":"M Hecking","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial","volume":"371","author":"J Weng","year":"2008","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.transproceed.2004.03.086","article-title":"Glycemic control during pancreas transplantation: continous infusion versus bolus","volume":"36","author":"H Halpern","year":"2004","journal-title":"Transplant Proc"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/TP.0b013e3181c478fd","article-title":"Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success","volume":"89","author":"A Koh","year":"2010","journal-title":"Transplantation"},{"issue":"suppl 2","key":"ref35","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.2337\/dcS13-2012","article-title":"How do we continue treatment in patients with type 2 diabetes when therapeutic goals are not reached with oral antidiabetes agents and lifestyle? Incretin versus insulin treatment","volume":"36","author":"B Gallwitz","year":"2013","journal-title":"Diabetes Care"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.metabol.2013.09.010","article-title":"Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells","volume":"63","author":"YS Lee","year":"2014","journal-title":"Metabolism"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.tp.0000251379.46596.2d","article-title":"Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes","volume":"83","author":"KA Ghofaili","year":"2007","journal-title":"Transplantation"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/en.2012-1983","article-title":"Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome","volume":"154","author":"M Padmasekar","year":"2013","journal-title":"Endocrinology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.2337\/dc13-1066","article-title":"Coadministration of liraglutide with tacrolimus in kidney transplant recipients: a case series","volume":"36","author":"NR Pinelli","year":"2013","journal-title":"Diabetes Care"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/TP.0b013e3182347ea4","article-title":"Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation","volume":"92","author":"JT Lane","year":"2011","journal-title":"Transplantation"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"SAVOR-TIMI 53 Steering Committee and Investigators. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"BM Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"EXAMINE Investigators. Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"WB White","year":"2013","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(12)60691-6","article-title":"2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial","volume":"380","author":"B Gallwitz","year":"2012","journal-title":"Lancet"},{"key":"ref44","article-title":"TECOS Study Group. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes","author":"JB Green","year":"2015","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"WC Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","article-title":"Diabetes Prevention Program Research Group. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study","volume":"379","author":"L Perreault","year":"2012","journal-title":"Lancet"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"c102","DOI":"10.1159\/000345159","article-title":"Relationship between body mass index and mortality in hemodialysis patients: a meta-analysis","volume":"121","author":"W Jialin","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/sdi.12109","article-title":"Kidney transplantation in the obese transplant candidates: to transplant or not to transplant?","volume":"26","author":"PT Pham","year":"2013","journal-title":"Semin Dial"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/ajt.12850","article-title":"Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions","volume":"14","author":"A Sharif","year":"2014","journal-title":"Am J Transplant"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C Monitoring Versus Tacrolimus) Investigators. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"F Vincenti","year":"2007","journal-title":"Am J Transplant"},{"issue":"suppl 3","key":"ref51","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00007890-201407151-00292","article-title":"Conversion from tacrolimus to cyclosporine A improves glucose metabolism in patients with new onset diabetes after transplantation: Interim analysis of a prospective and randomized study","volume":"14","author":"K Wissing","year":"2014","journal-title":"Am J Transplant"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/TP.0b013e318203c25f","article-title":"New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression","volume":"91","author":"FL Luan","year":"2011","journal-title":"Transplantation"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/TP.0b013e3181e58912","article-title":"A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation","volume":"90","author":"J Pascual","year":"2010","journal-title":"Transplantation"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/1573399811666150331160846","article-title":"Immunosuppression and Post-transplant Hyperglycemia","volume":"11","author":"N Montero","year":"2015","journal-title":"Curr Diabetes Rev"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature05097","article-title":"Calcineurin\/NFAT signalling regulates pancreatic beta-cell growth and function","volume":"443","author":"JJ Heit","year":"2006","journal-title":"Nature"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0134971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T05:13:44Z","timestamp":1653196424000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0134971"}},"subtitle":[],"editor":[{"given":"Juergen","family":"Eckel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,23]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0134971","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,23]]}}}